- provides a safe and clear environment for compounding of hazardous drug preparations in compliance with USP and criteria. It can be suited to get the job done involving dangerous components, antineoplastic, or cytotoxic compounding programs. The WHO's tips provide not only being a regulatory framework but additionally for a roadmap for mos